Bleeding
Q&A: Traumagel offers plant-based solution in bleeding control
In January, Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States.
Rivaroxaban tied to higher bleeding rates vs. low-dose aspirin
In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, rivaroxaban was associated with higher rates of major bleeding compared with low-dose aspirin, researchers reported.
Q&A: Lower blood thinner dose can reduce bleeding risk
Reduced dosing of direct oral anticoagulants may offer comparable efficacy as full dosing for adults with venous thromboembolism history while decreasing bleeding risk and reducing health care utilization, according to study results.
Data show ‘several gaps’ in care of adolescents with heavy menstrual bleeding
AIMS65 ‘reliable predictor’ of death, rebleeding after factor Xa reversal for GI bleeding
PHILADELPHIA — The AIMS65 risk score may help predict which patients with direct oral anticoagulant-associated gastrointestinal bleeding are at heightened risk for rebleeding and death, according to late-breaking data.
‘Lack of quality evidence’ to support prolonged vasoconstrictor use for variceal bleeding
PHILADELPHIA — Use of vasoconstrictors for up to 120 hours following endoscopic variceal ligation for acute variceal bleeding failed to demonstrate additional benefits vs. early discontinuation, according to data.
Gum bleeding raises odds for asthma symptoms, COPD 10 years later
Odds for asthma symptoms, COPD and chronic bronchitis went up if individuals reported earlier “often/always” vs. “never” gum bleeding, according to a poster presented at the European Respiratory Society International Congress.
Edoxaban reduced clinical events with less bleeding vs. dual therapy for AF, stable CAD
Edoxaban monotherapy for patients with atrial fibrillation and stable coronary disease reduced risk for adverse clinical events, mainly driven by lower bleeding risk, compared with dual antiplatelet therapy, a speaker reported.
FDA grants 510(k) clearance to hemostatic gel for moderate to severe bleeding
The FDA has granted 510(k) clearance to a plant-based, hemostatic gel to treat moderate to severe bleeding, according to the manufacturer.
Death, bleeding lower but stroke higher with radial access PCI vs. femoral access
Use of radial access for PCI has increased greatly in the U.S. over the last decade and is associated with lower risk for mortality, bleeding and nonfatal vascular complications compared with a transfemoral approach, a speaker reported.